Program to prevent blood clots in patients with spinal cord disorders
Effects of a Venous Thromboembolism Prevention Program on the Occurrence of Venous Thromboembolism in Patients With Spinal Cord Disorders
This study is testing a new program to see if it can help prevent blood clots in people with spinal cord disorders compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 42 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Khon Kaen University Academic / other |
| Locations | 1 site (Chaiyaphum) |
| Trial ID | NCT06302478 on ClinicalTrials.gov |
What this trial studies
This study examines the effectiveness of a venous thromboembolism prevention program, known as the '5E' program, in reducing blood clot rates among patients with spinal cord disorders. Participants will be divided into two groups: one receiving the 5E program, which includes education, leg elevation, ankle exercises, adequate fluid intake, and early use of intermittent pneumatic compression, and the other receiving standard care. The study aims to compare the rates of venous thromboembolism and related symptoms between the two groups, as well as measure changes in thigh and calf circumferences before and after the intervention.
Who should consider this trial
Good fit: Ideal candidates are patients with spinal cord disorders who have Caprini scores of 5-8 or greater and can communicate in Thai.
Not a fit: Patients experiencing complications such as neurogenic shock or autonomic dysreflexia, or those who are pregnant or have fluid restrictions, may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce the incidence of venous thromboembolism in patients with spinal cord disorders, improving their overall health outcomes.
How similar studies have performed: While similar programs have been implemented, the specific '5E' program's effectiveness in this patient population is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Caprini scores of 5-8 and \>8 * Able to communicate in the Thai language * Willing to participate in this study Exclusion Criteria: * Alteration of consciousness * Experiencing complications, including neurogenic shock and autonomic dysreflexia * Being pregnant * Having fluid restriction
Where this trial is running
Chaiyaphum
- Chaiyaphum Hospital — Chaiyaphum, Thailand (Recruiting)
Study contacts
- Study coordinator: Wiphawadee Potisopha, Ph.D.
- Email: wiphpo@kku.ac.th
- Phone: +660954291592
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.